Journal article

PS1157 EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL

P Ghia, I Flinn, N Lamanna, M Montillo, Á Illés, G Etienne, J Delgado, B Kuss, C Tam, F Offner, F Bosch, M Davids, U Jäger, F Cymbalista, D Weaver, S Lustgarten, H Youssoufian, S Stilgenbauer

HemaSphere | Ovid Technologies (Wolters Kluwer Health) | Published : 2019